nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—SLC22A7—Methotrexate—muscle cancer	0.246	0.5	CbGbCtD
Oxtriphylline—CYP1A2—Dacarbazine—muscle cancer	0.165	0.335	CbGbCtD
Oxtriphylline—CYP1A2—Etoposide—muscle cancer	0.0806	0.164	CbGbCtD
Oxtriphylline—HDAC2—Teniposide—Etoposide—muscle cancer	0.0212	1	CbGdCrCtD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—MYF6—muscle cancer	0.0138	0.0646	CbGpPWpGaD
Oxtriphylline—ADORA2B—smooth muscle tissue—muscle cancer	0.0121	0.0442	CbGeAlD
Oxtriphylline—HDAC2—embryo—muscle cancer	0.0109	0.0399	CbGeAlD
Oxtriphylline—PDE3B—bone marrow—muscle cancer	0.0106	0.0388	CbGeAlD
Oxtriphylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.0102	0.0475	CbGpPWpGaD
Oxtriphylline—SLC22A7—renal system—muscle cancer	0.00962	0.0351	CbGeAlD
Oxtriphylline—PDE4D—tendon—muscle cancer	0.00917	0.0335	CbGeAlD
Oxtriphylline—PDE3B—testis—muscle cancer	0.0091	0.0332	CbGeAlD
Oxtriphylline—PDE3A—smooth muscle tissue—muscle cancer	0.00893	0.0326	CbGeAlD
Oxtriphylline—PDE4C—head—muscle cancer	0.00893	0.0326	CbGeAlD
Oxtriphylline—HDAC2—smooth muscle tissue—muscle cancer	0.0086	0.0314	CbGeAlD
Oxtriphylline—ADORA2B—vagina—muscle cancer	0.00845	0.0308	CbGeAlD
Oxtriphylline—ADORA1—renal system—muscle cancer	0.00838	0.0306	CbGeAlD
Oxtriphylline—HDAC2—renal system—muscle cancer	0.00828	0.0302	CbGeAlD
Oxtriphylline—ADORA2B—head—muscle cancer	0.0078	0.0285	CbGeAlD
Oxtriphylline—PDE3A—cardiac atrium—muscle cancer	0.0077	0.0281	CbGeAlD
Oxtriphylline—PDE4D—testis—muscle cancer	0.00759	0.0277	CbGeAlD
Oxtriphylline—ADORA2B—testis—muscle cancer	0.00754	0.0275	CbGeAlD
Oxtriphylline—ADORA1—cardiac atrium—muscle cancer	0.0075	0.0274	CbGeAlD
Oxtriphylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.00727	0.034	CbGpPWpGaD
Oxtriphylline—HDAC2—Neural Crest Differentiation—PAX7—muscle cancer	0.00716	0.0335	CbGpPWpGaD
Oxtriphylline—PDE4A—testis—muscle cancer	0.00672	0.0245	CbGeAlD
Oxtriphylline—PDE3A—tendon—muscle cancer	0.00671	0.0245	CbGeAlD
Oxtriphylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.00654	0.0306	CbGpPWpGaD
Oxtriphylline—ADORA1—tendon—muscle cancer	0.00654	0.0239	CbGeAlD
Oxtriphylline—ADORA2A—head—muscle cancer	0.00649	0.0237	CbGeAlD
Oxtriphylline—HDAC2—tendon—muscle cancer	0.00646	0.0236	CbGeAlD
Oxtriphylline—ADORA2A—testis—muscle cancer	0.00627	0.0229	CbGeAlD
Oxtriphylline—HDAC2—bone marrow—muscle cancer	0.00626	0.0228	CbGeAlD
Oxtriphylline—SLC22A7—testis—muscle cancer	0.00622	0.0227	CbGeAlD
Oxtriphylline—HDAC2—Neural Crest Differentiation—PAX3—muscle cancer	0.00609	0.0285	CbGpPWpGaD
Oxtriphylline—ADORA1—vagina—muscle cancer	0.00607	0.0222	CbGeAlD
Oxtriphylline—HDAC2—vagina—muscle cancer	0.006	0.0219	CbGeAlD
Oxtriphylline—ADORA1—head—muscle cancer	0.00561	0.0205	CbGeAlD
Oxtriphylline—PDE3A—testis—muscle cancer	0.00556	0.0203	CbGeAlD
Oxtriphylline—PDE4B—cardiac atrium—muscle cancer	0.00555	0.0203	CbGeAlD
Oxtriphylline—HDAC2—head—muscle cancer	0.00554	0.0202	CbGeAlD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—CD34—muscle cancer	0.0055	0.0257	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—MYOD1—muscle cancer	0.0055	0.0257	CbGpPWpGaD
Oxtriphylline—ADORA1—testis—muscle cancer	0.00542	0.0198	CbGeAlD
Oxtriphylline—HDAC2—testis—muscle cancer	0.00535	0.0195	CbGeAlD
Oxtriphylline—PDE4B—tendon—muscle cancer	0.00484	0.0177	CbGeAlD
Oxtriphylline—HDAC2—Hedgehog signaling events mediated by Gli proteins—PTCH1—muscle cancer	0.00481	0.0225	CbGpPWpGaD
Oxtriphylline—PDE4B—bone marrow—muscle cancer	0.00469	0.0171	CbGeAlD
Oxtriphylline—PDE4B—vagina—muscle cancer	0.00449	0.0164	CbGeAlD
Oxtriphylline—PDE4D—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.00443	0.0207	CbGpPWpGaD
Oxtriphylline—HDAC2—Regulation of Telomerase—WT1—muscle cancer	0.00428	0.02	CbGpPWpGaD
Oxtriphylline—PDE4B—head—muscle cancer	0.00415	0.0151	CbGeAlD
Oxtriphylline—PDE4B—testis—muscle cancer	0.00401	0.0146	CbGeAlD
Oxtriphylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.004	0.0187	CbGpPWpGaD
Oxtriphylline—PDE4B—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.0039	0.0182	CbGpPWpGaD
Oxtriphylline—CYP1A2—renal system—muscle cancer	0.00381	0.0139	CbGeAlD
Oxtriphylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.0037	0.0173	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIDINS220—muscle cancer	0.00354	0.0166	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—PMS2—muscle cancer	0.00341	0.0159	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP73—muscle cancer	0.00317	0.0148	CbGpPWpGaD
Oxtriphylline—PDE3B—Leptin signaling pathway—FOXO1—muscle cancer	0.00293	0.0137	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KIDINS220—muscle cancer	0.00293	0.0137	CbGpPWpGaD
Oxtriphylline—PDE3B—IRS-related events triggered by IGF1R—IGF2—muscle cancer	0.00278	0.013	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP63—muscle cancer	0.00272	0.0127	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KIDINS220—muscle cancer	0.00272	0.0127	CbGpPWpGaD
Oxtriphylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.00272	0.0127	CbGpPWpGaD
Oxtriphylline—PDE3B—IGF1R signaling cascade—IGF2—muscle cancer	0.00271	0.0127	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—BUB1B—muscle cancer	0.00226	0.0106	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCRs, Other—CNR1—muscle cancer	0.00226	0.0106	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—KIT—muscle cancer	0.00211	0.00984	CbGpPWpGaD
Oxtriphylline—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.00201	0.00939	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—CDKN2A—muscle cancer	0.00171	0.00799	CbGpPWpGaD
Oxtriphylline—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.0017	0.00797	CbGpPWpGaD
Oxtriphylline—ADORA2B—C-MYB transcription factor network—PTGS2—muscle cancer	0.0016	0.00747	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.0015	0.007	CbGpPWpGaD
Oxtriphylline—SLC22A7—Fluoropyrimidine Activity—TP53—muscle cancer	0.00144	0.00671	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—ANGPT2—muscle cancer	0.00142	0.00666	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—CNR1—muscle cancer	0.00137	0.00641	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—ANGPT2—muscle cancer	0.0013	0.00606	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00128	0.00599	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00127	0.00595	CbGpPWpGaD
Oxtriphylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.00126	0.00587	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.0012	0.0056	CbGpPWpGaD
Oxtriphylline—HDAC2—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.00119	0.00558	CbGpPWpGaD
Oxtriphylline—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00118	0.00551	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—PTCH1—muscle cancer	0.00116	0.00541	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00109	0.0051	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—ANGPT2—muscle cancer	0.00104	0.00485	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—CDKN2A—muscle cancer	0.00103	0.00483	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—MDM2—muscle cancer	0.001	0.00469	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—FOXO4—muscle cancer	0.000991	0.00464	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—PTCH1—muscle cancer	0.000984	0.0046	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000982	0.00459	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—CNR1—muscle cancer	0.000976	0.00457	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KIDINS220—muscle cancer	0.000976	0.00456	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—FOXO4—muscle cancer	0.000922	0.00431	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KIDINS220—muscle cancer	0.000891	0.00417	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000885	0.00414	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KIDINS220—muscle cancer	0.000864	0.00404	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KIDINS220—muscle cancer	0.00085	0.00397	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000842	0.00394	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—CNR1—muscle cancer	0.00083	0.00388	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KIDINS220—muscle cancer	0.000809	0.00378	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KIDINS220—muscle cancer	0.000787	0.00368	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—MDM2—muscle cancer	0.000778	0.00364	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—PTCH1—muscle cancer	0.000759	0.00355	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KIDINS220—muscle cancer	0.000757	0.00354	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KIDINS220—muscle cancer	0.000749	0.0035	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—FOXO1—muscle cancer	0.000732	0.00342	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—IGF2—muscle cancer	0.000692	0.00324	CbGpPWpGaD
Oxtriphylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000685	0.0032	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—FOXO1—muscle cancer	0.000681	0.00318	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000674	0.00315	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—PTCH1—muscle cancer	0.000651	0.00304	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—CNR1—muscle cancer	0.000641	0.003	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—IGF2—muscle cancer	0.000631	0.00295	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KIDINS220—muscle cancer	0.000629	0.00294	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—CNR1—muscle cancer	0.000605	0.00283	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000594	0.00278	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KIDINS220—muscle cancer	0.000585	0.00273	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—PTCH1—muscle cancer	0.000576	0.00269	CbGpPWpGaD
Oxtriphylline—HDAC2—Cell Cycle—TP53—muscle cancer	0.000575	0.00269	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—PTCH1—muscle cancer	0.000566	0.00265	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KIT—muscle cancer	0.000558	0.00261	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000552	0.00258	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CNR1—muscle cancer	0.000549	0.00257	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NOTCH—TP53—muscle cancer	0.000545	0.00255	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—PTCH1—muscle cancer	0.000539	0.00252	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—CNR1—muscle cancer	0.000535	0.0025	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000531	0.00248	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—CNR1—muscle cancer	0.000526	0.00246	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—PTCH1—muscle cancer	0.000524	0.00245	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KIT—muscle cancer	0.000519	0.00243	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—PTCH1—muscle cancer	0.000505	0.00236	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—IGF2—muscle cancer	0.000504	0.00236	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CNR1—muscle cancer	0.000501	0.00234	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—CNR1—muscle cancer	0.000501	0.00234	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—PTCH1—muscle cancer	0.000499	0.00233	CbGpPWpGaD
Oxtriphylline—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.000489	0.00229	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—CNR1—muscle cancer	0.000487	0.00228	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CNR1—muscle cancer	0.000486	0.00227	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CNR1—muscle cancer	0.000478	0.00223	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000472	0.0022	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—CNR1—muscle cancer	0.000469	0.00219	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—CNR1—muscle cancer	0.000464	0.00217	CbGpPWpGaD
Oxtriphylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	0.000457	0.00214	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CNR1—muscle cancer	0.000455	0.00213	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP53—muscle cancer	0.000446	0.00209	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CNR1—muscle cancer	0.000443	0.00207	CbGpPWpGaD
Oxtriphylline—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000441	0.00206	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MED12—muscle cancer	0.000441	0.00206	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—MDM2—muscle cancer	0.000439	0.00205	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CNR1—muscle cancer	0.000426	0.00199	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CNR1—muscle cancer	0.000421	0.00197	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—MDM2—muscle cancer	0.000409	0.00191	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—TP53—muscle cancer	0.000403	0.00188	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PTCH1—muscle cancer	0.00039	0.00182	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTCH1—muscle cancer	0.000384	0.0018	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ENO2—muscle cancer	0.000373	0.00174	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000371	0.00174	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CNR1—muscle cancer	0.000362	0.00169	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTCH1—muscle cancer	0.000351	0.00164	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTCH1—muscle cancer	0.00034	0.00159	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HMGA1—muscle cancer	0.000339	0.00159	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTCH1—muscle cancer	0.000335	0.00156	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—TP53—muscle cancer	0.000334	0.00156	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FOXO4—muscle cancer	0.00033	0.00155	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CNR1—muscle cancer	0.000329	0.00154	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CNR1—muscle cancer	0.000324	0.00152	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTCH1—muscle cancer	0.000318	0.00149	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—TP53—muscle cancer	0.000311	0.00145	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTCH1—muscle cancer	0.00031	0.00145	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—FOXO4—muscle cancer	0.000304	0.00142	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FOXO4—muscle cancer	0.000302	0.00141	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTCH1—muscle cancer	0.000298	0.00139	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CNR1—muscle cancer	0.000296	0.00138	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTCH1—muscle cancer	0.000295	0.00138	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FOXO4—muscle cancer	0.000292	0.00137	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—VEGFA—muscle cancer	0.00029	0.00136	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FOXO4—muscle cancer	0.000288	0.00135	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CNR1—muscle cancer	0.000287	0.00134	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CNR1—muscle cancer	0.000282	0.00132	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FOXO4—muscle cancer	0.000274	0.00128	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CNR1—muscle cancer	0.000269	0.00126	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FOXO4—muscle cancer	0.000266	0.00125	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IGF2—muscle cancer	0.000265	0.00124	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—VEGFA—muscle cancer	0.000264	0.00124	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CNR1—muscle cancer	0.000261	0.00122	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FOXO4—muscle cancer	0.000256	0.0012	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FOXO4—muscle cancer	0.000253	0.00118	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CNR1—muscle cancer	0.000252	0.00118	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CNR1—muscle cancer	0.000249	0.00116	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTCH1—muscle cancer	0.000248	0.00116	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FOXO1—muscle cancer	0.000244	0.00114	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IGF2—muscle cancer	0.000242	0.00113	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IGF2—muscle cancer	0.000235	0.0011	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IGF2—muscle cancer	0.000231	0.00108	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTCH1—muscle cancer	0.00023	0.00108	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—FOXO1—muscle cancer	0.000225	0.00105	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FOXO1—muscle cancer	0.000223	0.00104	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IGF2—muscle cancer	0.00022	0.00103	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—muscle cancer	0.000219	0.00103	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FOXO1—muscle cancer	0.000216	0.00101	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IGF2—muscle cancer	0.000214	0.000999	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FOXO4—muscle cancer	0.000213	0.000996	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FOXO1—muscle cancer	0.000212	0.000993	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—VEGFA—muscle cancer	0.000211	0.000988	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CNR1—muscle cancer	0.000209	0.000977	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF2—muscle cancer	0.000206	0.000962	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF2—muscle cancer	0.000203	0.000951	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FOXO1—muscle cancer	0.000202	0.000946	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—muscle cancer	0.0002	0.000934	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000199	0.000928	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FOXO4—muscle cancer	0.000198	0.000926	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FOXO1—muscle cancer	0.000197	0.00092	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CNR1—muscle cancer	0.000194	0.000909	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FOXO1—muscle cancer	0.000189	0.000885	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FOXO1—muscle cancer	0.000187	0.000875	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KIT—muscle cancer	0.000186	0.000869	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KIT—muscle cancer	0.000171	0.0008	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF2—muscle cancer	0.000171	0.000799	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KIT—muscle cancer	0.00017	0.000793	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KIT—muscle cancer	0.000165	0.000769	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KIT—muscle cancer	0.000162	0.000757	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—muscle cancer	0.00016	0.000747	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF2—muscle cancer	0.000159	0.000743	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FOXO1—muscle cancer	0.000157	0.000735	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—FH—muscle cancer	0.000156	0.000732	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KIT—muscle cancer	0.000154	0.00072	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KIT—muscle cancer	0.00015	0.000701	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MDM2—muscle cancer	0.000146	0.000685	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FOXO1—muscle cancer	0.000146	0.000684	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KIT—muscle cancer	0.000144	0.000675	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KIT—muscle cancer	0.000143	0.000667	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MDM2—muscle cancer	0.000135	0.00063	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MDM2—muscle cancer	0.000134	0.000625	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—muscle cancer	0.00013	0.000607	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MDM2—muscle cancer	0.00013	0.000606	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MDM2—muscle cancer	0.000127	0.000596	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MDM2—muscle cancer	0.000121	0.000567	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KIT—muscle cancer	0.00012	0.00056	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MDM2—muscle cancer	0.000118	0.000552	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MDM2—muscle cancer	0.000114	0.000531	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MDM2—muscle cancer	0.000112	0.000525	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KIT—muscle cancer	0.000111	0.000521	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—muscle cancer	0.000111	0.00052	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—muscle cancer	0.000101	0.000474	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—muscle cancer	9.84e-05	0.00046	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—muscle cancer	9.68e-05	0.000453	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MDM2—muscle cancer	9.44e-05	0.000441	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—muscle cancer	9.22e-05	0.000431	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—muscle cancer	8.96e-05	0.000419	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MED12—muscle cancer	8.84e-05	0.000413	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MDM2—muscle cancer	8.77e-05	0.00041	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—muscle cancer	8.63e-05	0.000403	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—muscle cancer	8.53e-05	0.000399	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—muscle cancer	8.4e-05	0.000393	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO2—muscle cancer	8.06e-05	0.000377	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—muscle cancer	7.67e-05	0.000359	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—muscle cancer	7.44e-05	0.000348	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—muscle cancer	7.32e-05	0.000342	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—muscle cancer	7.17e-05	0.000335	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—muscle cancer	6.96e-05	0.000326	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—muscle cancer	6.77e-05	0.000317	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—muscle cancer	6.66e-05	0.000312	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—muscle cancer	6.52e-05	0.000305	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—muscle cancer	6.44e-05	0.000301	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.3e-05	0.000295	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—muscle cancer	5.42e-05	0.000253	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—muscle cancer	5.03e-05	0.000235	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—muscle cancer	2.81e-05	0.000131	CbGpPWpGaD
